Status:
COMPLETED
Olanzapine in the Treatment of Hair Pulling (Trichotillomania)
Lead Sponsor:
Hamilton Health Sciences Corporation
Collaborating Sponsors:
Eli Lilly and Company
Conditions:
Trichotillomania
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Trichotillomania (TTM) or hair-pulling has been considered as part of the obsessive compulsive disorder (OCD) spectrum, although treatment with OCD medications has largely been unsuccessful. Tics/Tour...
Eligibility Criteria
Inclusion
- primary DSM-IV trichotillomania; CGI-Severity ≥ 4
Exclusion
- Any other Axis I primary diagnosis; CGI-S \< 4; current comorbid: OCD, MDD, alcohol or substance abuse; lifetime hx of: schizophrenia, bipolar affective disorder or dementia; current pregnancy/lactation; current suicidality or homicidality; major medical problems or clinically unstable medical disease; hx of: seizures, stroke or head trauma; prior use of neuroleptics
Key Trial Info
Start Date :
June 1 2000
Trial Type :
INTERVENTIONAL
End Date :
March 1 2006
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT00182507
Start Date
June 1 2000
End Date
March 1 2006
Last Update
September 11 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamilton Health Sciences, McMaster University Medical Centre
Hamilton, Ontario, Canada, L8N 3Z5